Literature DB >> 8474687

Evidence for the localization of haemopexin immunoreactivity in neurones in the human brain.

C M Morris1, J M Candy, J A Edwardson, C A Bloxham, A Smith.   

Abstract

Haemopexin is a 60 kDa serum glycoprotein responsible for the transport of haem to tissues such as liver, by receptor-mediated endocytosis, in an analogous manner to the iron transport protein transferrin, with recycling of intact haemopexin. The immunocytochemical distribution of haemopexin has been investigated, using a monospecific polyclonal antiserum to human haemopexin, in human brain. Neurones in all the brain regions studied showed immunostaining of the soma, axons and dendrites. A few scattered glial cells exhibited positive immunostaining. Oligodendrocytes and choroid plexus epithelial cells lacked haemopexin immunoreactivity. Thus, haemopexin is present within neurones and we propose that this protein may play an important role in haem transport for neuronal iron homeostasis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8474687     DOI: 10.1016/0304-3940(93)90756-b

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  12 in total

1.  Kinetics and specificity of feline leukemia virus subgroup C receptor (FLVCR) export function and its dependence on hemopexin.

Authors:  Zhantao Yang; John D Philips; Raymond T Doty; Pablo Giraudi; J Donald Ostrow; Claudio Tiribelli; Ann Smith; Janis L Abkowitz
Journal:  J Biol Chem       Date:  2010-07-07       Impact factor: 5.157

2.  Heme-hemopexin complex attenuates neuronal cell death and stroke damage.

Authors:  Rung-chi Li; Sofiyan Saleem; Gehua Zhen; Wangsen Cao; Hean Zhuang; Jongseok Lee; Ann Smith; Fiorella Altruda; Emanuela Tolosano; Sylvain Doré
Journal:  J Cereb Blood Flow Metab       Date:  2009-03-11       Impact factor: 6.200

3.  A Chronic Fatigue Syndrome - related proteome in human cerebrospinal fluid.

Authors:  James N Baraniuk; Begona Casado; Hilda Maibach; Daniel J Clauw; Lewis K Pannell; Sonja Hess S
Journal:  BMC Neurol       Date:  2005-12-01       Impact factor: 2.474

Review 4.  Hemopexin and haptoglobin: allies against heme toxicity from hemoglobin not contenders.

Authors:  Ann Smith; Russell J McCulloh
Journal:  Front Physiol       Date:  2015-06-30       Impact factor: 4.566

Review 5.  Neuroprotective Role of the Nrf2 Pathway in Subarachnoid Haemorrhage and Its Therapeutic Potential.

Authors:  Ardalan Zolnourian; Ian Galea; Diederik Bulters
Journal:  Oxid Med Cell Longev       Date:  2019-05-02       Impact factor: 6.543

6.  Haemopexin affects iron distribution and ferritin expression in mouse brain.

Authors:  Noemi Morello; Elisabetta Tonoli; Federica Logrand; Veronica Fiorito; Sharmila Fagoonee; Emilia Turco; Lorenzo Silengo; Alessandro Vercelli; Fiorella Altruda; Emanuela Tolosano
Journal:  J Cell Mol Med       Date:  2009-10       Impact factor: 5.310

7.  Deletion of the hemopexin or heme oxygenase-2 gene aggravates brain injury following stroma-free hemoglobin-induced intracerebral hemorrhage.

Authors:  Bo Ma; Jason Patrick Day; Harrison Phillips; Bryan Slootsky; Emanuela Tolosano; Sylvain Doré
Journal:  J Neuroinflammation       Date:  2016-02-01       Impact factor: 8.322

Review 8.  A Review of Hematoma Components Clearance Mechanism After Subarachnoid Hemorrhage.

Authors:  Pengjie Pan; Li Xu; Hongrong Zhang; Yuan Liu; Xiaocheng Lu; Gang Chen; Hailiang Tang; Jiang Wu
Journal:  Front Neurosci       Date:  2020-07-07       Impact factor: 4.677

9.  Study protocol for SFX-01 after subarachnoid haemorrhage (SAS): a multicentre randomised double-blinded, placebo controlled trial.

Authors:  Ardalan H Zolnourian; Stephen Franklin; Ian Galea; Diederik Oliver Bulters
Journal:  BMJ Open       Date:  2020-03-25       Impact factor: 2.692

Review 10.  Therapeutic approaches to limit hemolysis-driven endothelial dysfunction: scavenging free heme to preserve vasculature homeostasis.

Authors:  Francesca Vinchi; Emanuela Tolosano
Journal:  Oxid Med Cell Longev       Date:  2013-05-27       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.